The market around low libido is enormous yet uneven. The landscape below explains what each category actually is, and what the evidence behind it does and doesn’t say.
03 - The options for HSDD
The HSDD Treatment Landscape
Four paths, side by side.
Reviewed against the criteria most relevant to a medical decision: regulatory oversight, clinical evidence, safety infrastructure, and dose-to-dose consistency.
1. FDA Approved Medications
Prescription medications studied specifically for both premenopausal and postmenopausal women with HSDD and reviewed and approved by the U.S. Food and Drug Administration.
FDA status
Reviewed & approved by the FDA for HSDD.
Clinical Evidence
Multiple Phase 3 randomized, double-blind, placebo-controlled trials, consisting of thousands of women nationwide.
Safety Monitoring
Standardized labeling, ongoing safety monitoring and post-market reporting.
Dose Consistency
Every dose is manufactured to the same federal standard, every time.
2. Compounded Medications & Hormone Injections and Creams
Custom-mixed formulations made by compounding pharmacies — often marketed online as personalized libido treatments.
FDA status
Not FDA-approved for HSDD.
Clinical Evidence
No required clinical trials. Marketing claims are typically not supported by substantial evidence.
Safety Monitoring
No required safety monitoring program.
Dose Consistency
Potency, sterility, and purity can vary between pharmacies, and sometimes between batches.
3. Over-the-Counter Supplements
Herbal “libido boosters” — maca, ashwagandha, horny goat weed, proprietary blends — sold without a prescription.
FDA status
Not FDA-approved for HSDD. Regulated as food, not medicine.
Clinical Evidence
Little to no rigorous evidence in HSDD specifically. Most studies are small, short, or industry-funded.
Safety Monitoring
No premarket safety review. Contamination and undisclosed ingredients are documented industry issues.
Dose Consistency
Active ingredient amounts can vary widely from the label.
4. Lifestyle, Therapy & Counseling
Sex therapy, couples counseling, cognitive-behavioral approaches, mindfulness, and addressing sleep, stress and medication contributors.
FDA status
Standardized clinical practice.
Clinical Evidence
Strong evidence for situational and relational low desire. Helpful adjunct for HSDD: rarely sufficient alone for biological HSDD.
Safety Monitoring
No medical risk profile. Requires time, access to a qualified provider, and (often) a willing partner.
Dose Consistency
Quality varies by clinician; best results come from providers trained in sexual medicine.
A Specific Public Paper Trail
What "FDA-approved" actually means
When a medication is FDA-approved, it has an indicated use that has gone through a defined process: pre-clinical study, three phases of human trials, manufacturing inspection, and a review of whether the benefit outweighs the risk for a defined population.
The label you read is also reviewed. The side effects you’re warned about are tracked. The dose you receive on Tuesday is the same dose you receive in March. None of this is glamorous, but it is the entire point of a heavily regulated system.
A Specific Public Paper Trail
A note on compounded "HSDD" products
Compounded medications fill a legitimate niche when a patient genuinely cannot use an approved drug. They are not, however, FDA-reviewed for safety or efficacy.
The FDA has issued warning letters to compounding pharmacies marketing unapproved testosterone or oral formulations for female sexual desire, citing concerns about unsubstantiated claims, dose variability, and the absence of safety data.
If you are considering a compounded product, the practical questions worth asking your clinician are: What is in it? At which dose? With what evidence? And who is monitoring me afterward?
The Next Conversation
None of this replaces a clinician who is trained in female sexual health and willing to listen carefully to help point you in the right direction.
Bring this comparison with you, or use our short conversation guide to help you say the first sentence out loud.